Perez D J, Powles T J, Milan J, Gazet J C, Ford H T, McCready V R, MacDonald J S, Coombes R C
Lancet. 1983 Sep 10;2(8350):613-6. doi: 10.1016/s0140-6736(83)90692-x.
Of 1116 patients receiving primary treatment for breast carcinoma at the Royal Marsden Hospital since 1976, 651 had an abnormal bone scintigram either at primary diagnosis (378) or on subsequent follow-up (273) and 167 developed radiographically detectable bone metastases (21 at the time of primary diagnosis). Comparison of bone scintigrams and X-rays showed that scintigraphy was an inaccurate localiser of existing radiographic detectable metastases. If X-rays alone are used to detect bone metastases a limited examination with five plates will detect metastases with 92% accuracy. After primary surgery, routine X-ray screening for bone metastases is not necessary since it is possible to identify patients at risk on the basis of clinical examination, chest X-ray, and serum alkaline phosphatase and gamma-glutamyl transpeptidase levels.
自1976年以来,在皇家马斯登医院接受乳腺癌初级治疗的1116例患者中,651例在初次诊断时(378例)或随后的随访中(273例)骨闪烁扫描异常,167例出现了X线可检测到的骨转移(21例在初次诊断时)。骨闪烁扫描与X线检查的比较表明,闪烁扫描对于已存在的X线可检测到的转移灶定位不准确。如果仅使用X线来检测骨转移,用五张片子进行有限的检查检测转移灶的准确率为92%。初次手术后,常规的骨转移X线筛查没有必要,因为根据临床检查、胸部X线以及血清碱性磷酸酶和γ-谷氨酰转肽酶水平来识别有风险的患者是可行的。